School of Medicine


Showing 221-240 of 280 Results

  • Irina Skylar-Scott

    Irina Skylar-Scott

    Clinical Assistant Professor, Neurology & Neurological Sciences

    BioDr. Skylar-Scott is a board-certified, fellowship-trained cognitive and behavioral neurologist and clinical assistant professor at Stanford University. She is a Diplomate of the American Board of Psychiatry and Neurology as well as the United Council for Neurologic Subspecialties in Behavioral Neurology and Neuropsychiatry.

    Her clinical interests include the treatment of cognitive and behavioral impairment due to Alzheimer’s disease, Parkinson’s disease, Lewy body dementia, posterior cortical atrophy, primary progressive aphasia, frontotemporal dementia, vascular dementia, primary age-related tauopathy, and limbic-predominant age-associated TDP-43 encephalopathy, among other disorders of cognition and behavior.

    Her research interests include clinical trials for Alzheimer’s disease and how social and intellectual engagement can affect cognition. She has also investigated impaired consciousness in epilepsy and biomarkers for assessing Duchenne muscular dystrophy. Prior to joining Stanford, Dr. Skylar-Scott was a fellow in the Center for Alzheimer’s Research and Treatment (CART) in the Department of Neurology at Harvard Medical School/Brigham and Women’s Hospital. She also completed her undergraduate degree at MIT, her MD at Yale, and her residency at Harvard.

    Dr. Skylar-Scott’s work has appeared in Neurology, Alzheimer's Research and Therapy, Pediatric Neurology, the Journal of Ultrasound in Medicine, Muscle & Nerve, and Epilepsia. She also has also been invited to write book chapters on Alzheimer’s disease, normal pressure hydrocephalus, Parkinson’s disease dementia and Lewy body dementia, and the cognitive and psychiatric consequences of neuroimmunological disorders published by Elsevier and McGraw-Hill.

    Presentations by Dr. Skylar-Scott have focused on prevention of cognitive decline in at-risk elderly people, cognitive and neuropsychiatric manifestations of Parkinson’s disease, human prion diseases, and other topics. She has presented at meetings held by the American Academy of Neurology (AAN), the American Neurological Association (ANA), and the American Academy of Neuromuscular and Electrodiagnostic Medicine (AANEM).

    For her research and scholarship, Dr. Skylar-Scott has earned honors from the American Academy of Neurology (AAN) and the Howard Hughes Medical Institute (HHMI). She was honored to receive the Golseth Young Investigator Award from the American Association of Neuromuscular & Electrodiagnostic Medicine. In addition, she won the Action Duchenne International Conference First Prize Poster for her research in Duchenne muscular dystrophy.

    Dr. Skylar-Scott is a member of the American Neurological Association and American Academy of Neurology. Every year, she walks to raise money for Alzheimer's disease and Lewy body dementia.

  • Yuen So, MD, PhD

    Yuen So, MD, PhD

    Professor of Neurology (Adult Neurology)
    On Partial Leave from 02/01/2024 To 08/18/2024

    Current Research and Scholarly InterestsResearch in the diagnosis, pathophysiology and treatment of peripheral neuropathy, myasthenia gravis, motor neuron diseases including ALS and SMA, nerve injuries and muscle diseases. Application of clinical neurophysiological methods to neurological diagnosis. Development of evidence-based medicine pertaining to the practice of neurology.

  • Anirudh Sreekrishnan

    Anirudh Sreekrishnan

    Affiliate, Neurology

    BioDr. Anirudh Sreekrishnan is a vascular neurology fellow with research interests in quality improvement within acute stroke care, imaging of stroke and intracerebral hemorrhage, and stroke outcomes. He completed his medical education at Yale School of Medicine with a Masters in Health Science and research in intracerebral hemorrhage outcomes. He then pursued his neurology training at Harvard Medical School affiliated with the Mass General Brigham Hospitals in Boston. Dr. Sreekrishnan plans to continue working as an academic neurologist and neurovascular clinician after fellowship.

  • Kristen K. Steenerson, MD

    Kristen K. Steenerson, MD

    Clinical Assistant Professor, Otolaryngology (Head and Neck Surgery)
    Clinical Assistant Professor, Neurology & Neurological Sciences

    BioKristen Steenerson is a board-certified neurologist with fellowship training in otoneurology. After graduating cum laude from Claremont McKenna College where she was honored as an All-American lacrosse defensive player, she continued on to medical school at the University of Utah in Salt Lake City, Utah. After four years of excellent training and annual ski passes, she proceeded to the Mayo Clinic in Arizona for neurology residency. There, she discovered the beauty of the Sonoran Desert as well as an unmet need in balance disorders and vertigo, motivating her to pursue a fellowship in otoneurology at Barrow Neurological Institute. She joins Stanford with positions in both Otolaryngology--Head and Neck Surgery and Neurology with the goal of jointly addressing the junction of inner ear and brain disorders. Her specific interests include vestibular migraine, benign paroxysmal positional vertigo, Ménière's disease and international neurology.

  • James Stieger

    James Stieger

    Postdoctoral Scholar, Neurology and Neurological Sciences

    BioJames earned his PhD in Biomedical Engineering from the University of Minnesota. His research was focused on brain computer interfaces using EEG signals. His interests lie in the intersection of machine learning and real-time brain recording. James joined the LBCN with the intent to discover how focal brain activity can be harnessed to decode brain function and how to improve it in conditions such as epilepsy.

  • Minhui Su

    Minhui Su

    Postdoctoral Scholar, Neurology and Neurological Sciences

    BioMinhui Su, PhD is a postdoctoral fellow at the Neurology Department. She is investigating neuronal activity-regulated glioma growth, specifically how membrane depolarization regulates glioma growth in the tumor microenvironment.

    She obtained her PhD in Molecular Biology, with a focus on neuroimmunology, at the International Max Planck Research School (IMPRS) at Georg August University Göttingen, Germany. Her PhD research discovered that inflammation is an essential early step of myelin regeneration, and uncovered the roles of microglia (the resident immune cells of the central nervous system) in myelin damage response.

    She enjoys science, art and hiking in her free time.

  • Lia Talozzi

    Lia Talozzi

    Postdoctoral Scholar, Neurology and Neurological Sciences

    BioDr. Talozzi aims to contribute to the definition of quantitative biomarkers for neurological pathologies. She has a physics background, and a master's in applied physics. She graduated with honors from Bologna University, where she pursued her Ph.D. in Biomedical and Neuromotor Sciences. During her doctoral studies, she worked primarily with magnetic resonance imaging, majoring in tractography methods, for which she was awarded a scholarship at the Neuroanatomy and Tractography Laboratory, King's College London. Subsequently, she exploited dimensionality reduction techniques for associating white matter damage with clinical symptoms within the Bordeaux University Disconnectome ERC grant. Currently, she expanded her research horizons to genetic investigations by joining the Greicius Lab. She aims to develop novel strategies for modeling risk scores for Alzheimer's pathology using long read sequencing methodologies.

  • Ryan Taylor, MD

    Ryan Taylor, MD

    Clinical Assistant Professor, Neurology & Neurological Sciences

    BioDr. Taylor is a fellowship-trained neurologist and assistant professor in the Department of Neurology and Neurological Sciences, Memory Disorders Division. He provides patient care at the Stanford Center for Memory Disorders.

    His areas of expertise include diagnosing and treating illnesses that impair thinking, memory, behavior, and speech. Dr. Taylor’s clinical focus includes Alzheimer’s disease, Lewy body disease, frontotemporal dementia, primary progressive aphasia, posterior cortical atrophy, Creutzfeldt-Jakob disease, autoimmune encephalitis and other rapidly progressive dementias. He works with patients and families to provide diagnostic clarity and individualized treatment plans.

    Dr. Taylor’s academic and research interests combine clinical and scientific understandings of dementia with a philosophical inquiry into the structure of conscious experience. His original clinical research includes diverse topics, such as advances in diagnosing Creutzfeldt-Jakob disease and the clinical characterization of adult-onset hereditary dementias. Dr. Taylor has published work instrumental in identifying the potential role of fentanyl in a syndrome of sudden onset amnesia that emerged during the opioid crisis.

    He has presented research at the American Academy of Neurology and published in peer-reviewed journals, including the Canadian Journal of Neurological Sciences and Methods in Molecular Biology. He has also published a chapter on the diagnosis and treatment of frontotemporal dementia and was a reviewer for Neurocase.

    Dr. Taylor is a fellow of the Royal College of Physicians of Canada. He has taught residents and medical students clinical skills, neuroanatomy, neuro-imaging, and other subjects. He also has delivered Grand Rounds presentations on dementia, epilepsy, and pediatric neurology.

  • Kate Therkelsen, MD

    Kate Therkelsen, MD

    Clinical Assistant Professor, Neurology & Neurological Sciences

    BioDr. Therkelsen is a board-certified, fellowship-trained neuro-oncologist with the Stanford Medicine Cancer Center and a clinical assistant professor in the Department of Neurology and Neurological Sciences.

    She diagnoses and treats a wide range of conditions including primary brain tumors and cancers of the central nervous system, metastatic disease to the brain and spinal cord, and neurologic complications of cancer. She prepares a personalized, comprehensive care plan for each patient she serves.

    Dr. Therkelsen’s research interests include clinical trials of new therapeutics, as well as ways to reduce toxicities that some patients may experience when receiving cancer treatment. Her fellowship research projects included a study of survival and long-term function among patients treated for primary central nervous system lymphoma. She also received a pre-doctoral National Institutes of Health Intramural Research Training Award for her work with the Framingham Heart Study.

    She has published in Current Treatment Options in Oncology and other peer-reviewed journals. She has presented to her peers at international, national, and regional meetings, including the annual meetings of the Society of Neuro-Oncology and of the American Academy of Neurology.

    Dr. Therkelsen is a member of the Society of Neuro-Oncology and the American Academy of Neurology.